As of May 26
| -0.42 / -0.77%|
The 21 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 58.00, with a high estimate of 68.00 and a low estimate of 40.00. The median estimate represents a +7.47% increase from the last price of 53.97.
The current consensus among 24 polled investment analysts is to Buy stock in Bristol-Myers Squibb. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.